Read Roche's Latest Drug Marks a Milestone in KRAS-Driven Lung Cancer Treatment LifeMedicine Roche's Latest Drug Marks a Milestone in KRAS-Driven Lung Cancer Treatment Roche's new drug has been approved, potentially setting a new standard for treating KRAS-driven lung cancer, amidst a thriving biotech sector. Editorial Staff 11 days ago
Read Roche's Strong Accusations Against U.S. Drug Review Practices Raise Concerns LifeMedicine Roche's Strong Accusations Against U.S. Drug Review Practices Raise Concerns Roche has leveled serious accusations against the U.S., claiming 'blackmail' tactics amid ongoing controversies surrounding drug reviews and skinny labels. Editorial Staff about 1 month ago
